Mechanisms of endothelial cell protection by blockade of the JAK2 pathway

American Journal of Physiology - Cell Physiology

Volumn 292, Issue 3, 2007, Pages

  Neria, Fernando ^a   Caramelo, Carlos ^a   Peinado, Héctor ^b   González Pacheco, Francisco R ^a   Deudero, Juan Jp ^a   De Solis, Alain J ^a   Fernández Sánchez, Ruth ^a   Peñate, Silvia ^a   Cano, Amparo ^b   Castilla, Ma Ángeles ^a,b  

^a Hospital UniversitarioFundación Jiménez Díaz   (Spain)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

AG490; Anoikis; Cytoprotection; JAK2 STAT

Indexed keywords

BETA CATENIN; CD31 ANTIGEN; JANUS KINASE 2; N BENZYL 2 CYANO 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE; PROTEIN KINASE B; PROTEIN TYROSINE KINASE INHIBITOR; STAT PROTEIN;

ANIMAL CELL; ARTICLE; ASTROCYTE; CELL DAMAGE; CELL PROTECTION; DEPHOSPHORYLATION; DRUG MECHANISM; ENDOTHELIUM CELL; ENZYME INHIBITION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; THROMBOCYTE ADHESION; VASCULAR SMOOTH MUSCLE;

ANIMALS; CATTLE; CELL SURVIVAL; CELLS, CULTURED; CYTOPROTECTION; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; HUMANS; JANUS KINASE 2; SIGNAL TRANSDUCTION; TYRPHOSTINS;

EID: 33947315607     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00548.2005     Document Type: Article

References (31)

1. Banes AK, Shaw SM, Tawfik A, Patel BP, Ogbi S, Fulton D, Marrero MB. Activation of the JAK/STAT pathway in vascular smooth muscle by serotonin. Am J Physiol Cell Physiol 288: C805-C812, 2005.
2. Biswas P, Canosa S, Schoenfeld J, Schoenfeld D, Tucker A, Madri JA. PECAM-1 promotes beta-catenin accumulation and stimulates endothelial cell proliferation. Biochem Biophys Res Commun 303: 212-218, 2003.
3. Bussolino F, Di Renzo MF, Ziche M, Bocchietto E, Olivero M, Naldini L, Gaudino G, Tamagnone L, Coffer A, Comoglio PM. Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J Cell Biol 119: 629-641, 1992.
4. Castilla MA, Arroyo MV, Aceituno E, Aragoncillo P, Gonzalez-Pacheco FR, Texeiro E, Bragado R, Caramelo C. Disruption of cadherin-related junctions triggers autocrine expression of vascular endothelial growth factor in bovine aortic endothelial cells : effects on cell proliferation and death resistance. Circ Res 85: 1132-1138, 1999.
5. Castilla MA, Caramelo C, Gazapo RM, Martin O, Gonzalez-Pacheco FR, Tejedor A, Bragado R, Arroyo MV. Role of vascular endothelial growth factor (VEGF) in endothelial cell protection against cytotoxic agents. Life Sci 67: 1003-1013, 2000.
6. Castilla MA, Neria F, Renedo G, Pereira DS, Gonzalez-Pacheco FR, Jimenez S, Tramon P, Deudero JJ, Arroyo MV, Yague S, Caramelo C. Tumor-induced endothelial cell activation: role of vascular endothelial growth factor. Am J Physiol Cell Physiol 286: C1170-C1176, 2004.
7. Dejana E. Endothelial cell-cell junctions: happy together. Nat Rev Mol Cell Biol 5: 261-270, 2004.
8. Doble BW, Woodgett JR. GSK-3: tricks of the trade for a multi-tasking kinase. J Cell Sci 116: 1175-1186, 2003.
9. Dudley AC, Thomas D, Best J, Jenkins A. The STATs in cell stress-type responses. Cell Commun Signal 2: 8, 2004.
10. El Adawi H, Deng L, Tramontano A, Smith S, Mascareno E, Ganguly K, Castillo R, El Sherif N. The functional role of the JAK-STAT pathway in post-infarction remodeling. Cardiovasc Res 57: 129-138, 2003.
11. Gorina R, Petegnief V, Chamorro A, Planas AM. AG490 prevents cell death after exposure of rat astrocytes to hydrogen peroxide or proinflammatory cytokines: involvement of the Jak2/STAT pathway. J Neurochem 92: 505-518, 2005.
12. Grossmann J. Molecular mechanisms of "detachment-induced apoptosis-Anoikis." Apoptosis 7: 247-260, 2002.
13. Harada M, Qin Y, Takano H, Minamino T, Zou Y, Toko H, Ohtsuka M, Matsuura K, Sano M, Nishi J, Iwanaga K, Akazawa H, Kunieda T, Zhu W, Hasegawa H, Kunisada K, Nagai T, Nakaya H, Yamauchi-Takihara K, Komuro I. G-CSF prevents cardiac remodeling after myocardial infarction by activating the Jak-Stat pathway in cardiomyocytes. Nat Med 11: 305-311, 2005.
14. Hatsell S, Rowlands T, Hiremath M, Cowin P. Beta-catenin and Tcfs in mammary development and cancer. J Mammary Gland Biol Neoplasia 8: 145-158, 2003.
15. Hattori R, Maulik N, Otani H, Zhu L, Cordis G, Engelman RM, Siddiqui MA, Das DK. Role of STAT3 in ischemic preconditioning. J Mol Cell Cardiol 33: 1929-1936, 2001.
16. Hortelano S, Castilla M, Torres AM, Tejedor A, Bosca L. Potentiation by nitric oxide of cyclosporin A and FK506-induced apoptosis in renal proximal tubule cells. J Am Soc Nephrol 11: 2315-2323, 2000.
17. Ilan N, Tucker A, Madri JA. Vascular endothelial growth factor expression, beta-catenin tyrosine phosphorylation, and endothelial proliferative behavior: a pathway for transformation? Lab Invest 83: 1105-1115, 2003.
18. Kim HS, Skurk C, Thomas SR, Bialik A, Suhara T, Kureishi Y, Birnbaum M, Keaney JF Jr, Walsh K. Regulation of angiogenesis by glycogen synthase kinase-3beta. J Biol Chem 277: 41888-41896, 2002.
19. Liu W, Davis DW, Ramirez K, McConkey DJ, Ellis LM. Endothelial cell apoptosis is inhibited by a soluble factor secreted by human colon cancer cells. Int J Cancer 92: 26-30, 2001.
20. Mascareno E, El Shafei M, Maulik N, Sato M, Guo Y, Das DK, Siddiqui MA. JAK/STAT signaling is associated with cardiac dysfunction during ischemia and reperfusion. Circulation 104: 325-329, 2001.
21. Maziere C, Conte MA, Maziere JC. Activation of JAK2 by the oxidative stress generated with oxidized low-density lipoprotein. Free Radic Biol Med 31: 1334-1340, 2001.
22. Meydan N, Grunberger T, Dadi H, Shahar M, Arpaia E, Lapidot Z, Leeder JS, Freedman M, Cohen A, Gazit A, Levitzki A, Roifman CM. Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor. Nature 379: 645-648, 1996.
23. Michel JB. Anoikis in the cardiovascular system: known and unknown extracellular mediators. Arterioscler Thromb Vasc Biol 23: 2146-2154, 2003.
24. Neria F, Caramelo C, Peinado H, Gonzalez-Pacheco FR, Deudero JJ, de solis AJ, Fernandez Sanchez R, peñate S, Cano A, Castilla MA. Endothelial protection by inhibition of the JAK/STAT pathway in monolayer and detached EC (Abstract). Nefrología 25: 7, 2005.
25. Oda Y, Renaux B, Bjorge J, Saifeddine M, Fujita DJ, Hollenberg MD. cSrc is a major cytosolic tyrosine kinase in vascular tissue. Can J Physiol Pharmacol 77: 606-617, 1999.
26. Orford K, Orford CC, Byers SW. Exogenous expression of beta-catenin regulates contact inhibition, anchorage-independent growth, anoikis, and radiation-induced cell cycle arrest. J Cell Biol 146: 855-868, 1999.
27. Sandberg EM, Sayeski PP. Jak2 tyrosine kinase mediates oxidative stress-induced apoptosis in vascular smooth muscle cells. J Biol Chem 279: 34547-34552, 2004.
28. Uchimura H, Marumo T, Takase O, Kawachi H, Shimizu F, Hayashi M, Saruta T, Hishikawa K, Fujita T. Intrarenal injection of bone marrow-derived angiogenic cells reduces endothelial injury and mesangial cell activation in experimental glomerulonephritis. J Am Soc Nephrol 16: 997-1004, 2005.
29. Weng Z, Xin M, Pablo L, Grueneberg D, Hagel M, Bain G, Muller T, Papkoff J. Protection against anoikis and down-regulation of cadherin expression by a regulatable beta-catenin protein. J Biol Chem 277: 18677-18686, 2002.
30. Yadav A, Kalita A, Banerjee K. JAK/STAT3 pathway is involved in survival of neurons in response to insulin like growth factor and negatively regulated by suppression of cytokine signaling-3. J Biol Chem 280: 31830-31840, 2005.
31. Yahata Y, Shirakata Y, Tokumaru S, Yamasaki K, Sayama K, Hanakawa Y, Detmar M, Hashimoto K. Nuclear translocation of phosphorylated STAT3 is essential for vascular endothelial growth factor-induced human dermal microvascular endothelial cell migration and tube formation. J Biol Chem 278: 40026-40031, 2003.